Source: Annual Congress 2013 –New drugs in respiratory medicine
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Spears, C. McSharry, R. Chaudhuri, K. Nocka, G. Miele, W. T. Lee, M. Shepherd, N. Thomson (Glasgow, Manchester, United Kingdom; Cambridge, United States Of America). Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD. Eur Respir J 2013; 42: Suppl. 57, 1582

Member's Comments

No comment yet.

Related content which might interest you: Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects Source: International Congress 2016 – Mechanisms of disease Year: 2016 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Differential bronchial epithelial gene expression in COPD versus controls Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 MUC1-CT mediates corticosteroid responses in COPD Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Higher burden of asthma symptoms and increased blood eosinophils in ACOS Source: International Congress 2016 – Systemic biomarkers Year: 2016 Bronchial epithelial gene expression of NOX isoforms are related to important clinical characteristics in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Lung function decline in COPD in relation to MMP-12 and surfactant protein A Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013